Evanthia Tatsidou, Costas Tsiamis, Evika Karamagioli, Georgios Boudouris, Andreas Pikoulis, Eleni Kakalou, Emmanuel Pikoulis

Reflecting upon the humanitarian use of unmanned aerial vehicles (drones)

Swiss Med Wkly. 2019;149:w20065

Hopes are very high that drones will provide extraordinary help to emergency response teams. On the other hand, critics are concerned about the real value of this technology.

Marcus Mumme, Anke Wixmerten, Sylvie Miot, Andrea Barbero, Alexandre Kaempfen, Franziska Saxer, Sebastian Gehmert, Andreas Krieg, Dirk J. Schaefer, Marcel Jakob, Ivan Martin

Tissue engineering for paediatric patients

Swiss Med Wkly. 2019;149:w20032

Tissue engineering approaches in a paediatric population are particularly relevant because of the critical need for transplant material and the small amount of accessible autologous graft tissue.

Sophie S. Wang, Yang Yang, Julia Velz, Emanuela Keller, Andreas R. Luft, Luca Regli, Marian C. Neidert, Oliver Bozinov

Management of brainstem haemorrhages

Swiss Med Wkly. 2019;149:w20062

Primary brainstem haemorrhages remain associated with poor outcomes compared to other forms of spontaneous intracranial haemorrhage. Their management needs re-evaluation and reinvestigation to update the relevant data.

Benoîte Mery, Alexis Vallard, Elise Rowinski, Nicolas Magne

High-throughput sequencing in clinical oncology: from past to present

Swiss Med Wkly. 2019;149:w20057

Major improvements in biotechnology and bioinformatics have been achieved over the past two decades, allowing the development of omic signatures of several molecular subtypes of cancer, each associated with different outcomes.

Panagiotis Samaras, Mario Bargetzi, Daniel C. Betticher, Christoph Driessen, Michel A. Duchosal, Dominik Heim, Nicolas Ketterer, Erika Lerch, Thomas Matthes, Ulrich Mey, Thomas Pabst, Adrian Schmidt, Christian Taverna, Thilo Zander, Christoph Renner

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Swiss Med Wkly. 2019;149:w20031

The recent increase in knowledge about multiple myeloma necessitated an update of the guidelines published 3 years ago.

Francesca Compagno, Klaudia Naegele, Christian R. Kahlert, Irene Hösli, Karoline Aebi-Popp, Begona Martinez de Tejada, Paolo Paioni, Sabine Yerly, Jürg Böni, Manuel Battegay, Christoph Rudin, Hans H. Hirsch, the Swiss HIV Cohort Study

The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study

Swiss Med Wkly. 2019;149:w20059

Combination anti-retroviral therapy (cART) has reduced mother-to-child transmission (MTCT) and improved the prognosis of HIV-infected newborns. However, drug resistance mutations (DRM) either transmitted by MTCT (HIV-tDRM) or selected by suboptimal adherence and drug levels (HIV-sDRM) remain a concern.

Claire Da Costa-Demaurex, Maria T. Cárdenas, Hernando Aparicio, Patrick Bodenmann, Blaise Genton, Valérie D’Acremont

Screening strategy for Chagas disease in a non-endemic country (Switzerland): a prospective evaluation

Swiss Med Wkly. 2019;149:w20050

Knowledge of the positive predictors for Chagas disease is important to better target screening for the highest risk population. Another important element in the design of an effective screening strategy is the type of diagnostic test to be used.

Erratum to: Molecular imaging for neuroendeocrine tumours

Swiss Med Wkly. 2019;149:w20076

Erratum to: Clinical characteristics, audiological and neurodevelopmental outcomes of newborns with congenital cytomegalovirus infection

Swiss Med Wkly. 2019;149:w20075